Lake Street Maintains Buy on OptimizeRx, Lowers Price Target to $11

Benzinga Newsdesk www.benzinga.com Negative 51.0%

Neg 51% Neu 0% Pos 0%

Lake Street analyst Eric Martinuzzi maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $20 to $11.